ARTICLE | Clinical News
Xyzal Allergy 24HR regulatory update
February 9, 2017 9:52 PM UTC
Sanofi said FDA approved Xyzal Allergy 24HR levocetirizine for OTC use to treat symptoms associated with seasonal and year-round allergies. Sanofi expects Xyzal Allergy 24HR will be available in spri...
BCIQ Target Profiles